Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation

Microbial Cell Factories

Volumn 19, Issue 1, 2020, Pages

  Gunzburg, Walter H ^a,b   Aung, Myo Myint ^a   Toa, Pauline ^a   Ng, Shirelle ^a   Read, Eliot ^a   Tan, Wee Jin ^a   Brandtner, Eva Maria ^a,c   Dangerfield, John ^a   Salmons, Brian ^a  

^a Austrianova Singapore   (Singapore)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c Vorarlberg Institute for Vascular Investigation and Treatment   (Austria)

Author keywords

Acid protection; Cellulose sulphate; Encapsulation; Gut microbiome dysbiosis; Living cell encapsulation; Microbiota; Probiotics

Indexed keywords

CELLULASE; CELLULOSE SULFATE; MICROSPHERE; PROBIOTIC AGENT; CELLULOSE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL STRAIN; CELL ENCAPSULATION; CELL VIABILITY; COMMENSAL ESCHERICHIA COLI; CONCENTRATION (PARAMETER); CONTROLLED STUDY; IN VITRO STUDY; INTESTINE FLORA; MICROENCAPSULATION; MOUSE; NONHUMAN; PH; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTESTINE; MALE; MICROBIAL VIABILITY; MICROBIOLOGY; NUDE MOUSE; PROCEDURES; STOMACH JUICE;

ANIMALS; CELL ENCAPSULATION; CELLULASE; CELLULOSE; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ESCHERICHIA COLI; GASTRIC JUICE; GASTROINTESTINAL MICROBIOME; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; MALE; MICE; MICE, NUDE; MICROBIAL VIABILITY; MICROSPHERES; PROBIOTICS;

EID: 85096652834     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/s12934-020-01465-3     Document Type: Article

References (55)

1. Wieërs G, Belkhir L, Enaud R, et al. How probiotics affect the microbiota. Front Cell Infect Microbiol. 2019;9:454. DOI: 10.3389/fcimb.2019.00454
2. Ogunrinola GA, Oyewale JO, Oshamika OO, Olasehinde GI. The human microbiome and its impacts on health. Int J Microbiol. 2020;2020:1–7. DOI: 10.1155/2020/8045646
3. Valles-Colomer M, Falony G, Darzi Y, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019;4:623–32. DOI: 10.1038/s41564-018-0337-x
4. Lai CY, Sung J, Cheng F, et al. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther. 2019;49:354–63. DOI: 10.1111/apt.15116
5. Ding WK, Shah NP. Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria. J Food Sci. 2007;72:M446-450. DOI: 10.1111/j.1750-3841.2007.00565.x
6. Culligan EP, Hill C, Sleator RD. Probiotics and gastrointestinal disease: successes, problems and future prospects. Gut Pathogens. 2009;1:19. DOI: 10.1186/1757-4749-1-19
7. Su MS, Schlicht S, Gänzle MG. Contribution of glutamate decarboxylase in Lactobacillus reuteri to acid resistance and persistence in sourdough fermentation. Microb Cell Fact. 2011;10:S8. DOI: 10.1186/1475-2859-10-S1-S8
8. Ilhan ZE, Marcus AK, Kang D-W, Rittmann BE, Krajmalnik-Brown R. pH-mediated microbial and metabolic interactions in fecal enrichment cultures. mSphere. 2017;2:e00047-e00117. DOI: 10.1128/mSphere.00047-17
9. Govender M, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V. A review of the advancements in probiotic delivery: conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2014;15:29–43. DOI: 10.1208/s12249-013-0027-1
10. Terpou A, Papadaki A, Lappa IK, Kachrimanidou V, Bosnea LA, Kopsahelis N. Probiotics in food systems: significance and emerging strategies towards improved viability and delivery of enhanced beneficial value. Nutrients. 2019;11:1591. DOI: 10.3390/nu11071591
11. Ulleberg EK, Comi I, Holm H, Herud EB, Jacobsen M, Vegarud GE. Human gastrointestinal juices intended for use in in vitro digestion models. Food Digest. 2011;2:52–61. DOI: 10.1007/s13228-011-0015-4
12. Ziarno M, Zaręba D. Effects of milk components and food additives on survival of three bifidobacteria strains in fermented milk under simulated gastrointestinal tract conditions. Microb Ecol Health Dis. 2015. 10.3402/mehd.v26.27812. DOI: 10.3402/mehd.v26.27812
13. Chandramouli V, Kailasapathy K, Peiris P, Jones M. An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J Microbiol Methods. 2004;56:27–35. DOI: 10.1016/j.mimet.2003.09.002
14. Krasaekoopt W, Bhandari B, Deeth H. The influence of coating materials on some properties of alginate beads and survivability of microencapsulated probiotic bacteria. Int Dairy J. 2004;14:737–43. DOI: 10.1016/j.idairyj.2004.01.004
15. Khosravi Zanjani MA, Ghiassi Tarzi B, Sharifan A, Mohammadi N. Microencapsulation of probiotics by calcium alginate-gelatinized starch with chitosan coating and evaluation of survival in simulated human gastro-intestinal condition. Iran J Pharm Res. 2014;13:843–52.
16. Zhu H. Bacterial killing in gastric juice—effect of pH and pepsin on Escherichia coli and Helicobacter pylori. J Med Microbiol. 2006;55:1265–70. DOI: 10.1099/jmm.0.46611-0
17. Salmons B, Brandtner EM, Hettrich K, et al. Encapsulated cells to focus the metabolic activation of anticancer drugs. Curr Opin Mol Ther. 2010;12:450–60.
18. Rokka S, Rantamäki P. Protecting probiotic bacteria by microencapsulation: challenges for industrial applications. Eur Food Res Technol. 2010;231:1–12. DOI: 10.1007/s00217-010-1246-2
19. Li W, Liu L, Tian H, Luo X, Liu S. Encapsulation of Lactobacillus plantarum in cellulose based microgel with controlled release behavior and increased long-term storage stability. Carbohydr Polym. 2019;223:115065. DOI: 10.1016/j.carbpol.2019.115065
20. Chen B, Lin X, Lin X, Li W, Zheng B, He Z. Pectin-microfibrillated cellulose microgel: effects on survival of lactic acid bacteria in a simulated gastrointestinal tract. Int J Biol Macromol. 2020;158:826–36. DOI: 10.1016/j.ijbiomac.2020.04.161
21. Singh P, Medronho B, Alves L, da Silva GJ, Miguel MG, Lindman B. Development of carboxymethyl cellulose-chitosan hybrid micro- and macroparticles for encapsulation of probiotic bacteria. Carbohydr Polym. 2017;175:87–95. DOI: 10.1016/j.carbpol.2017.06.119
22. Fijałkowski K, Peitler D, Rakoczy R, Żywicka A. Survival of probiotic lactic acid bacteria immobilized in different forms of bacterial cellulose in simulated gastric juices and bile salt solution. LWT - Food Science and Technology. 2016;68:322–8. DOI: 10.1016/j.lwt.2015.12.038
23. Kwiecień I, Kwiecień M. Application of polysaccharide-based hydrogels as probiotic delivery systems. Gels. 2018;4:47. DOI: 10.3390/gels4020047
24. Cronin M, Stanton RM, Francis KP, Tangney M. Bacterial vectors for imaging and cancer gene therapy: a review. Cancer Gene Ther. 2012;19:731–40. DOI: 10.1038/cgt.2012.59
25. Both E, Gyorgy E, Kibedi-Szabo CZ, et al. Acid and bile tolerance, adhesion to epithelial cells of probiotic microorganisms. UPB Bull Sci Ser B Chem Mater Sci. 2010;72:37–44.
26. Foucault M-L, Thomas L, Goussard S, Branchini BR, Grillot-Courvalin C. In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice. Appl Environ Microbiol. 2010;76:264–74. DOI: 10.1128/AEM.01686-09
27. Waidmann MS, Bleichrodt FS, Laslo T, Riedel CU. Bacterial luciferase reporters: the Swiss army knife of molecular biology. Bioeng Bugs. 2011;2:8–16. DOI: 10.4161/bbug.2.1.13566
28. Baban CK, Cronin M, Akin AR, et al. Bioluminescent bacterial imaging in vivo. J Vis Exp. 2012;69:e4318.
29. Cronin M, Akin AR, Collins SA, et al. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS ONE. 2012;7:e30940. DOI: 10.1371/journal.pone.0030940
30. Winiarczyk S, Gradski Z, Kosztolich B, et al. A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study. J Mol Med. 2002;80:610–4. DOI: 10.1007/s00109-002-0356-0
31. Salmons B, Hauser O, Gunzburg WH, Tabotta W. GMP production of an encapsulated cell therapy product: issues and considerations. Bioprocess J. 2007;4:36–43.
32. Mojaverian P, Ferguson RK, Vlasses PH, et al. Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition. Gastroenterology. 1985;89:392–7. DOI: 10.1016/0016-5085(85)90342-7
33. Ariffin H, Abdullah N, Umi Kalsom MS, Shirai Y, Hassan MA. Production and characterization of cellulase by Bacillus pumilus EB3. Int J Eng Tech. 2006;3:47–53.
34. Hong HA, Khaneja R, Tam NMK, et al. Bacillus subtilis isolated from the human gastrointestinal tract. Res Microbiol. 2009;160:134–43. DOI: 10.1016/j.resmic.2008.11.002
35. Schwarz R, Kaspar A, Seelig J, Künnecke B. Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance. Magn Reson Med. 2002;48:255–61. DOI: 10.1002/mrm.10207
36. Padmanabhan P, Grosse J, Asad ABMA, Radda GK, Golay X. Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT. EJNMMI research. 2013;3:60. DOI: 10.1186/2191-219X-3-60
37. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–76. DOI: 10.1016/j.cell.2015.02.047
38. Ramos PE, Cerqueira MA, Teixeira JA, Vicente AA. Physiological protection of probiotic microcapsules by coatings. Crit Rev Food Sci Nutr. 2018;58:1864–77. DOI: 10.1080/10408398.2017.1289148
39. Gbassi G, Vandamme T, Ennahar S, Marchioni E. Microencapsulation of Lactobacillus plantarum spp in an alginate matrix coated with whey proteins. Int J Food Microbiol. 2009;129:103–5. DOI: 10.1016/j.ijfoodmicro.2008.11.012
40. Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV. Production and evaluation of dry alginate-chitosan microcapsules as an enteric delivery vehicle for probiotic bacteria. Biomacromol. 2011;12:2834–40. DOI: 10.1021/bm200576h
41. Ding WK, Shah NP. An improved method of microencapsulation of probiotic bacteria for their stability in acidic and bile conditions during storage. J Food Sci. 2009;74:M53–61. DOI: 10.1111/j.1750-3841.2008.01030.x
42. Anselmo AC, McHugh KJ, Webster J, Langer R, Jaklenec A. Layer-by-layer encapsulation of probiotics for delivery to the microbiome. Adv Mater. 2016;28:9486–90. DOI: 10.1002/adma.201603270
43. de Vuyst L, Avonts L, Makras L. Probiotics, prebiotics and gut health. In: Remacle C, Reusens B, editors. Functional foods, ageing and degenerative disease. Swaston: Woodhead Publishing; 2004. p. 416–82. DOI: 10.1533/9781855739017.3.416
44. Shortt C. The probiotic century: historical and current perspectives. Trends Food Sci Technol. 1999;10:411–7. DOI: 10.1016/S0924-2244(00)00035-2
45. Salmons B, Dangerfield D, Gunzburg W. Delivery of probiotics efficiently to the intestine: the acid test. NuFFooDS Spectrum Asia. 2020. https://www.nuffoodsspectrum.asia/analysis/54/1525/delivery-of.
46. Salmons B, Gunzburg WH. Release characteristics of cellulose sulphate capsules and production of cytokines from encapsulated cells. Int J Pharm. 2018;548:15–22. DOI: 10.1016/j.ijpharm.2018.06.040
47. Leatham MP, Banerjee S, Autieri SM, Mercado-Lubo R, Conway T, Cohen PS. Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157: H7 growth in the streptomycin-treated mouse intestine. Infect Immun. 2009;77:2876–86. DOI: 10.1128/IAI.00059-09
48. Escribano-Vazquez U, Verstraeten S, Martin R, et al. The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model. Sci Rep. 2019;9:11431. DOI: 10.1038/s41598-019-47611-9
49. Escribano-Vazquez U, Beimfohr C, Bellet D, et al. Symbioflor2® Escherichia coli genotypes enhance ileal and colonic gene expression associated with mucosal defense in gnotobiotic mice. Microorganisms. 2020;8:512. DOI: 10.3390/microorganisms8040512
50. Slavin JL, Brauer PM, Marlett JA. Neutral detergent fiber, hemicellulose and cellulose digestibility in human subjects. The Journal of Nutrition. 1981;111:287–97. DOI: 10.1093/jn/111.2.287
51. Wedekind KJ, Mansfield HR, Montgomery L. Enumeration and isolation of cellulolytic and hemicellulolytic bacteria from human feces. Appl Environ Microbiol. 1988;54:1530–5. DOI: 10.1128/AEM.54.6.1530-1535.1988
52. Chassard C, Delmas E, Robert C, Bernalier-Donadille A. The cellulose-degrading microbial community of the human gut varies according to the presence or absence of methanogens: Cellulolytic microbiota and CH4 production in the human gut. FEMS Microbiol Ecol. 2010;74:205–13. DOI: 10.1111/j.1574-6941.2010.00941.x
53. Robert C, Bernalier-Donadille A. The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects. FEMS Microbiol Ecol. 2003;46:81–9. DOI: 10.1016/S0168-6496(03)00207-1
54. Betian HG, Linehan BA, Bryant MP, Holdeman LV. Isolation of a cellulotytic Bacteroides sp. from human feces. Appl Environ Microbiol. 1977;33:1009–10. DOI: 10.1128/AEM.33.4.1009-1010.1977
55. Culligan E, Sleator R. Advances in the microbiome: applications to Clostridium difficile infection. J Clin Med. 2016;5:83. DOI: 10.3390/jcm5090083